Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.

Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O, Laguna T, Joseph J, Dynoodt P, Aura C, Foth M, Cloots R, van den Hurk K, Balint B, Murphy IG, McDermott EW, Sheahan K, Jirström K, Nodin B, Mallya-Udupi G, van den Oord JJ, Gallagher WM, Esteller M.

BMC Med. 2017 Jun 5;15(1):101. doi: 10.1186/s12916-017-0851-3.

2.

Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.

Byström S, Fredolini C, Edqvist PH, Nyaiesh EN, Drobin K, Uhlén M, Bergqvist M, Pontén F, Schwenk JM.

Transl Oncol. 2017 Jun;10(3):385-395. doi: 10.1016/j.tranon.2017.03.002. Epub 2017 Apr 20.

3.

Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.

Blokzijl A, Chen LE, Gustafsdottir SM, Vuu J, Ullenhag G, Kämpe O, Landegren U, Kamali-Moghaddam M, Hedstrand H.

PLoS One. 2016 Apr 25;11(4):e0154214. doi: 10.1371/journal.pone.0154214. eCollection 2016.

4.

Emerging clinical applications of selected biomarkers in melanoma.

Tetzlaff MT, Torres-Cabala CA, Pattanaprichakul P, Rapini RP, Prieto VG, Curry JL.

Clin Cosmet Investig Dermatol. 2015 Jan 30;8:35-46. doi: 10.2147/CCID.S49578. eCollection 2015. Review.

5.

Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.

Beard RE, Abate-Daga D, Rosati SF, Zheng Z, Wunderlich JR, Rosenberg SA, Morgan RA.

Clin Cancer Res. 2013 Sep 15;19(18):4941-50. doi: 10.1158/1078-0432.CCR-13-1253. Epub 2013 Sep 10.

6.

SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis.

Cronin JC, Watkins-Chow DE, Incao A, Hasskamp JH, Schönewolf N, Aoude LG, Hayward NK, Bastian BC, Dummer R, Loftus SK, Pavan WJ.

Cancer Res. 2013 Sep 15;73(18):5709-18. doi: 10.1158/0008-5472.CAN-12-4620. Epub 2013 Aug 1.

7.

A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections.

Rexhepaj E, Agnarsdóttir M, Bergman J, Edqvist PH, Bergqvist M, Uhlén M, Gallagher WM, Lundberg E, Ponten F.

PLoS One. 2013 May 17;8(5):e62070. doi: 10.1371/journal.pone.0062070. Print 2013.

8.

SOXs in human prostate cancer: implication as progression and prognosis factors.

Zhong WD, Qin GQ, Dai QS, Han ZD, Chen SM, Ling XH, Fu X, Cai C, Chen JH, Chen XB, Lin ZY, Deng YH, Wu SL, He HC, Wu CL.

BMC Cancer. 2012 Jun 15;12:248. doi: 10.1186/1471-2407-12-248.

9.

Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery.

Prassas I, Chrystoja CC, Makawita S, Diamandis EP.

BMC Med. 2012 Apr 19;10:39. doi: 10.1186/1741-7015-10-39.

10.

Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.

Seong I, Min HJ, Lee JH, Yeo CY, Kang DM, Oh ES, Hwang ES, Kim J.

PLoS One. 2012;7(2):e31477. doi: 10.1371/journal.pone.0031477. Epub 2012 Feb 21.

Supplemental Content

Support Center